title: Cyclosporin combined with levamisole for refractory or relapsed severe aplastic anaemia.
authors.forename: Yingqi
authors.initials: Y
authors.lastname: Shao
authors.forename: Xingxin
authors.initials: X
authors.lastname: Li
authors.forename: Jun
authors.initials: J
authors.lastname: Shi
authors.forename: Meili
authors.initials: M
authors.lastname: Ge
authors.forename: Jinbo
authors.initials: J
authors.lastname: Huang
authors.forename: Zhendong
authors.initials: Z
authors.lastname: Huang
authors.forename: Jing
authors.initials: J
authors.lastname: Zhang
authors.forename: Neng
authors.initials: N
authors.lastname: Nie
authors.forename: Yizhou
authors.initials: Y
authors.lastname: Zheng
mesh_terms: D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000188:drug therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007978:Levamisole / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D016879:Salvage Therapy; D013601:T-Lymphocytes; D055815:Young Adult
chemical_list: D000961:Antilymphocyte Serum; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D007978:Levamisole; D016572:Cyclosporine
keywords: cyclosporin; levamisole; refractory; relapsed; severe aplastic anaemia